IBM’s Preliminary Q2 Miss Sends Shares Tumbling, Undercutting Wave of Analyst Optimism
Published on 07/14/2026 at 20:42 | Redaktion boerse-global.de
The divergence between Wall Street’s enthusiasm for International Business Machines and the company’s own early reckoning of its second-quarter performance could hardly have been starker. Just days after Citigroup hoisted its price target to a Street-high $375 and Barclays, Morgan Stanley and JPMorgan upgraded the stock, IBM released preliminary figures that fell well short of consensus expectations, triggering a massive sell-off. The shares cratered roughly 25% to €192.00, wiping out gains built on a strong first quarter and a flurry of bullish analyst calls.
The preliminary Q2 report showed revenue of $17.2 billion, up just 1% year-over-year and missing the $17.86 billion analysts had penciled in. Adjusted earnings per share landed at $2.93, also below the roughly $3.00 the market was anticipating. The revenue and profit shortfalls contrast sharply with the consensus that had given a 90% probability of an earnings beat, based on Polymarket forecasts. IBM plans to publish its full quarterly results at the end of July.
Chief Executive Arvind Krishna attributed the weakness to a pronounced shift in customer spending priorities. Clients are rushing to secure server and storage hardware for artificial intelligence deployments, concerned about rising prices, and that scramble is starving IBM’s software segment of investment dollars. The mainframe business, which had shown explosive growth in the first quarter—infrastructure revenue surged 51%—lost momentum as the quarter progressed. Krishna acknowledged the company was slow to adapt to the changing demand patterns, adding that several large deals failed to close as planned and that cybersecurity worries further distracted clients from new software projects.
The move sent the Relative Strength Index to 30.4, a level typically considered oversold, but the damage to investor sentiment has been severe. IBM stock now trades more than 13% below its 52-week high of €292.85 set on June 1 and roughly 9% above its 50-day moving average of €230.65, a cushion that has thinned considerably. The market capitalization stood at €236.78 billion before the sell-off.
Should investors sell immediately? Or is it worth buying IBM?
The downbeat report stands in stark contrast to the momentum IBM carried into the quarter. In Q1, the company posted earnings per share of $1.91, topping estimates of $1.81, while revenue grew 9.5% to $15.92 billion. Software revenue rose 11.3%, Red Hat added 13%, and the infrastructure division’s operating margin nearly doubled from 8.6% to 15.8%. Those results, coupled with a growing AI book of business now exceeding $12.5 billion in cumulative orders, had fueled the analyst upgrades. Citigroup’s Fatima Boolani set the new $375 target, while Barclays initiated with Overweight and a $350 price objective. The consensus still sits at a Moderate Buy with an average target of $306.28, though that baseline will likely face downward pressure after the preliminary numbers.
Longer-term strategic bets remain unchanged. IBM is ploughing $10 billion into quantum computing over the next five years, and early July saw a landmark quantum calculation in fusion research alongside the Oak Ridge National Laboratory and the Cleveland Clinic. A partnership with OpenAI is intended to deepen the company’s AI capabilities. Yet these initiatives are not yet generating meaningful revenue to offset the near-term softness. New security software like Lightwell is still in its early stages.
For income-focused investors, IBM offers some insulation. The quarterly dividend was raised to $1.69 per share, yielding roughly 2.3% annualized. With a forward price-to-earnings multiple of 23 for 2026—well below Oracle’s 31—the stock is not expensive by sector standards, but the valuation argument loses force when earnings are slipping. Management continues to target constant-currency revenue growth above 5% for the full year and an increase in free cash flow of about $1 billion.
IBM at a turning point? This analysis reveals what investors need to know now.
The coming weeks will be pivotal. The full Q2 earnings release on July 22 will either confirm the preliminary snapshot or offer revisions. Much depends on whether the delayed large-scale software deals can be salvaged and whether the mainframe business can regain its first-quarter pace. For now, the market has issued a harsh verdict that has silenced the optimistic chatter, leaving IBM to prove that its long-term narrative can withstand a messy quarter.
Ad
IBM Stock: New Analysis - 14 July
Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
